Charles H. Jackson Jr.

Charles Jackson serves as a Contracting Officer responsible for managing complex acquisitions in the scientific and biotechnological research domain. He plays a pivotal role in executing the agency’s procurement mission by ensuring compliance with federal acquisition regulations while advancing mission-critical R&D objectives. His portfolio primarily consists of service-based contracts for scientific research, laboratory support, and analytical technology development, often requiring specialized technical expertise and rigorous performance metrics. Jackson specializes in sole-source and competitive negotiated procurements under FAR Part 15, frequently engaging with firms possessing advanced capabilities in life sciences and engineering research. While no specific contractor relationships are currently identifiable in the dataset, Jackson’s procurement patterns indicate consistent engagement with firms possessing deep domain expertise in biotechnology and physical sciences research. He maintains a results-driven approach to vendor selection, prioritizing technical capability, past performance, and compliance with federal standards over volume-based contracting. His working relationships reflect a focus on long-term, high-integrity partnerships with firms capable of delivering innovative, mission-aligned solutions under time-sensitive and scientifically rigorous conditions. Jackson demonstrates a strong preference for open competition, with 88.9% of his acquisitions issued without set-aside designations. However, he actively supports small business participation, with 11.1% of awards directed toward Total Small Business Set-Asides under FAR 19.5. This reflects a measured commitment to socioeconomic goals without compromising technical requirements, aligning with agency priorities to foster innovation while maintaining procurement integrity. His primary procurement focus lies in NAICS 541714 (Research and Development in Biotechnology) and NAICS 541712 (Research and Development in the Physical, Engineering, and Life Sciences), indicating deep expertise in procuring services related to molecular biology, drug discovery, clinical research support, and advanced laboratory instrumentation. He routinely awards contracts for proprietary research protocols, data analytics, and translational science initiatives, requiring contractors with proven experience in regulated scientific environments and compliance with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP).